Dandan Hu
About
Dandan Hu is a scholar working on Hepatology, Surgery and Oncology.
According to data from OpenAlex, Dandan Hu has authored 148 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 28 papers in Surgery and 26 papers in Oncology. Recurrent topics in Dandan Hu's work include Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Liver Disease Diagnosis and Treatment (14 papers). Dandan Hu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Liver Disease Diagnosis and Treatment (14 papers). Dandan Hu collaborates with scholars based in China, United States and Montenegro. Dandan Hu's co-authors include Yi‐Dong Li, Minshan Chen, Yuqian Ye, Yilei Mao, Huayu Yang, Yaojun Zhang, Zhibo Xie, Yuning Sun, Yangxun Pan and Fei Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Dandan Hu
137 papers receiving 2.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Dandan Hu China | 26 | 364 | 334 | 293 | 279 | 228 | 148 | 2.1k | ||
| Jun Lin China | 32 | 210 0.6× | 715 2.1× | 285 1.0× | 73 0.3× | 131 0.6× | 120 | 2.6k | ||
| Yujun Zhang China | 25 | 298 0.8× | 914 2.7× | 200 0.7× | 98 0.4× | 374 1.6× | 199 | 2.5k | ||
| Yuan Zhou China | 28 | 165 0.5× | 672 2.0× | 164 0.6× | 54 0.2× | 189 0.8× | 86 | 2.3k | ||
| Leonardo R. Andrade Brazil | 34 | 219 0.6× | 1.1k 3.4× | 306 1.0× | 52 0.2× | 305 1.3× | 110 | 3.5k | ||
| Bram C. J. van der Eerden Netherlands | 32 | 410 1.1× | 1.6k 4.9× | 335 1.1× | 35 0.1× | 440 1.9× | 131 | 4.2k | ||
| Yan Huang China | 30 | 172 0.5× | 1.2k 3.6× | 61 0.2× | 303 1.1× | 162 0.7× | 155 | 2.9k | ||
| Hang Jiang China | 27 | 243 0.7× | 704 2.1× | 277 0.9× | 52 0.2× | 109 0.5× | 119 | 3.1k | ||
| Xiaolin He China | 35 | 150 0.4× | 1.7k 5.0× | 189 0.6× | 54 0.2× | 464 2.0× | 85 | 4.2k | ||
| Kenji Sakai Japan | 33 | 371 1.0× | 1.5k 4.5× | 696 2.4× | 76 0.3× | 231 1.0× | 206 | 3.8k | ||
| Jinrong Li China | 27 | 113 0.3× | 554 1.7× | 184 0.6× | 25 0.1× | 90 0.4× | 184 | 2.3k |
Countries citing papers authored by Dandan Hu
Since
Specialization
Citations
This map shows the geographic impact of Dandan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dandan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dandan Hu more than expected).
Fields of papers citing papers by Dandan Hu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Dandan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dandan Hu. The network helps show where Dandan Hu may publish in the future.
Co-authorship network of co-authors of Dandan Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Dandan Hu. A scholar is included among the top collaborators of Dandan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dandan Hu. Dandan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chen, Jinbin, Juncheng Wang, Yizhen Fu, et al.. (2025). Comparing PD ‐L1 and PD ‐1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single‐center, real‐world study. International Journal of Cancer. 156(10). 1972–1985.
2.
Zhang, Yaojun, Jinbin Chen, Zhongguo Zhou, et al.. (2025). Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma. Radiology. 314(2). e241096–e241096.
3.
Wang, Zhiyou, et al.. (2025). Associations of Grandparenting Dimensions/Styles with Mental Health in Children and Adolescents: A Systematic Review and Meta-Analysis. Behavioral Sciences. 15(2). 180–180.
4.
Wang, Qianyu, Hu Li, Juncheng Wang, et al.. (2024). Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC. Frontiers in Immunology. 15. 1469302–1469302.
5.
Fu, Yizhen, Zili Hu, Yangxun Pan, et al.. (2024). Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study. Frontiers in Immunology. 15. 1494520–1494520.
6.
Westerband, Andrea C., et al.. (2024). Temperature and plant-available soil phosphorus drive intraspecific variation in plant economic traits of Schima superba across an elevation gradient. Annals of Botany. 136(5-6). 1323–1337.
7.
Wang, Xin, Yizhen Fu, Weijie Wu, et al.. (2024). YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment. Molecular Cancer. 23(1). 186–186.
8.
Wu, Weijie, Hao Zou, Zhongguo Zhou, et al.. (2024). The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab. Frontiers in Immunology. 15. 1474456–1474456.
9.
Li, Ziyang, et al.. (2024). Spinal histamine H4 receptor mediates chronic pruritus via p‐ERK in acetone–ether–water (AEW )‐induced dry skin mice. Experimental Dermatology. 33(7). e15128–e15128.
10.
Wang, Litian, et al.. (2024). 20(S)-Protopanaxatriol Improves Atherosclerosis by Inhibiting Low-Density Lipoprotein Receptor Degradation in ApoE KO Mice. Journal of Cardiovascular Pharmacology. 84(1). 45–57.
11.
Wang, Jiongliang, Yangxun Pan, Juncheng Wang, et al.. (2024). Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study. International Journal of Surgery. 111(1). 1552–1557.
12.
Wu, Weijie, et al.. (2023). Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 1849–1859.
13.
Wang, Jiongliang, Juncheng Wang, Yangxun Pan, et al.. (2023). Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy. Journal of Hepatocellular Carcinoma. Volume 10. 2133–2145.
14.
Hu, Dandan, Yi‐Dong Li, Yunxuan Weng, Huaqiao Peng, & Jian‐Bing Zeng. (2023). Mussel inspired stable underwater superoleophobic cotton fabric combined with carbon nanotubes for efficient oil/water separation and dye adsorption. Applied Surface Science. 631. 157566–157566.
15.
Hu, Zili, Yizhen Fu, Dandan Hu, et al.. (2023). Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 1157–1167.
16.
Fu, Yizhen, Zili Hu, Yangxun Pan, et al.. (2022). Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma. Journal of Inflammation Research. Volume 15. 5721–5731.
17.
Jiang, Lingmin, Wei He, Jiliang Qiu, et al.. (2022). More Liver Metastases Detected Intraoperatively Indicates Worse Prognosis for Colorectal Liver Metastases Patients after Resection Combined with Microwave Ablation. Journal of Oncology. 2022. 1–8.
18.
Chen, Xiaoping, et al.. (2022). Divergent leaf nutrient-use strategies of coexistent evergreen and deciduous trees in a subtropical forest. Journal of Plant Ecology. 16(4).
19.
Chen, Xiaoping, Karl J. Niklas, Zhaoying Wang, et al.. (2021). A whole‐plant economics spectrum including bark functional traits for 59 subtropical woody plant species. Journal of Ecology. 110(1). 248–261.
20.
Pan, Yangxun, Jinbin Chen, Dandan Hu, et al.. (2020). Single versus multiple port laparoscopic left lateral sectionectomy for hepatocellular carcinoma: A retrospective comparative study. International Journal of Surgery. 77. 15–21.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jun Lin Breakdown of academic impact, for papers by Yujun Zhang Breakdown of academic impact, for papers by Yuan Zhou Breakdown of academic impact, for papers by Leonardo R. Andrade Breakdown of academic impact, for papers by Bram C. J. van der Eerden Breakdown of academic impact, for papers by Yan Huang Breakdown of academic impact, for papers by Hang Jiang Breakdown of academic impact, for papers by Xiaolin He Breakdown of academic impact, for papers by Kenji Sakai Breakdown of academic impact, for papers by Jinrong Li